MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST) Files An 8-K Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure

On December 15, 2017, Medifirst Solutions, Inc. (the “Company”) issued a press release announcing that the Company engaged Life Science Quest, LLC, a consulting group that specializes in globally developing and commercializing the products of health care and life sciences companies (“Life Quest”).

A copy of the press release is attached herewith as Exhibit 99.1.

In addition, attached herewith as Exhibit 99.2 is a copy of a press release dated December 8, 2017, which press release provided shareholders with an update on various Company initiatives, including the commencement of discussions with Life Quest.

The information in this Item 7.01 disclosure, including Exhibit 99.1 and Exhibit 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. In addition, the information in this Item 7.01 disclosure, including Exhibits 99.1, shall not be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Medifirst Solutions, Inc. Exhibit
EX-99.1 2 f8k121417ex99-1_medifirst.htm PRESS RELEASE DATED DECEMBER 14,…
To view the full exhibit click here

About MEDIFIRST SOLUTIONS, INC (OTCMKTS:MFST)

Medifirst Solutions, Inc. is a development-stage company. The Company is engaged in developing medical devices. The Company, under a manufacturing agreement, produces its hand-held mobile laser system known as The Time Machine Program. Through its subsidiary Medical Laser Manufacturer, Inc., the Company has entered into a Product and Know-How License Agreement (the License Agreement) with Laser Lab Corp to license the use of various properties in connection with seeking regulatory approval for and marketing, distributing and selling The Time Machine Series Lasers (TTM Series). In addition to the license granted to the Company, the License Agreement provides for an option to license other fields of use of the infrared laser in the TTM Series, as well as other wavelengths and colors, allowing the Company to develop a range of product offerings. The Time Machine Infrared Laser 810/830-nanometer (nm) operates in continuous wave mode set at a fixed frequency.